 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stealth BioTherapeutics Corp Announces Completion of Merger Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON, Nov. 16, 2022 BOSTON, Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the 'Company' or 'Stealth...

Stealth BioTherapeutics Corp Announces Completion of Merger

Stealth BioTherapeutics Corp (NASDAQ:MITO Get Rating) was the target of a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 193,100 shares, a decrease of 29.2% from the October 15th total of 272,900 shares. Based on an average daily ...

Stealth BioTherapeutics Corp (NASDAQ:MITO) Short Interest Update

Stealth BioTherapeutics Corp (NASDAQ:MITO  Get Rating) was the target of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 193,100 shares, a decrease of 29.2% from the October 15th total of 272,900 shares. Based on an average daily ...

Stealth BioTherapeutics Corp (NASDAQ:MITO) Short Interest Down 29.2% in October

Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire BOSTON...

Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire BOSTON, Oct. 7, 2022 BOSTON, Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO...

Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders

Stealth Biotherapeutics chief financial officer Robert Weiskopf leaves company

Stealth BioTherapeutics Announces Departure of Chief Financial Officer Stealth BioTherapeutics Announces Departure of Chief Financial Officer PR Newswire BOSTON, Sept. 30, 2022 BOSTON, Sept. 30, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company...

Stealth BioTherapeutics Announces Departure of Chief Financial Officer

Stealth BioTherapeutics Corp (NASDAQ:MITO  Get Rating) was the recipient of a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 377,300 shares, an increase of 103.5% from the August 15th total of 185,400 shares. Based on an ...

Short Interest in Stealth BioTherapeutics Corp (NASDAQ:MITO) Grows By 103.5%

Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events PR Newswire BOSTON, Sept. 15, 2022 BOSTON, Sept. 15, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage...

Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events

Stealth BioTherapeutics Corp (NASDAQ:MITO  Get Rating) was the recipient of a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 270,200 shares, a decline of 24.8% from the July 15th total of 359,200 shares. Based on an average ...

Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. The company was founded in 2007 and is based in Newton, Massachusetts, United States.

Watchers	3,567
52-Wk Low	$0.1621
52-Wk High	$1.00

Market Cap	$20.98M
Volume (M)	1.3M
52-Wk High	$1.00
52-Wk Low	$0.1621

MITO Stealth BioTherapeutics Corp

About

Feed

News

Fundamentals